Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Preclinical Study: TLD-1433 vs Conjunctival Melanoma

<< Previous

Bullboard Posts

Next >>

Comment by FGPstockon Jan 19, 2023 3:08pm

225 Views

Post# 35233992

RE:Preclinical Study: TLD-1433 vs Conjunctival Melanoma

Dr McFarland started on this quest to cure melanoma as she had it. If I had cancer i think patient would want it off label, but I am not sure if too many doctors will treat patients right away due to the liability as I believe the procedure will be different for each indication and it may take a while until we see off label treatments. imo

<< Previous

Bullboard Posts

Next >>

AI companies to invest in